Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Jpn J Infect Dis ; 72(1): 7-13, 2019 Jan 23.
Article in English | MEDLINE | ID: mdl-30175734

ABSTRACT

The aim of this study was to evaluate the prevalence of nasopharyngeal (NP) carriage and the serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in children with chronic diseases, which predisposes them to invasive pneumococcal disease in comparison with that in healthy children. A cross-sectional prevalence study was performed between February 2015 and February 2016 in Istanbul, Turkey. We enrolled 1,024 children with chronic diseases and 394 healthy children aged 0-18 years. The overall prevalence of S. pneumoniae NP (SPNP) carriage was 9.8%, with 8.4% in healthy children and 10.3% in children with chronic diseases. The prevalence rates of SPNP carriage were 17.5%, 13.5%, 10.5%, 9.3%, 8.6%, 8.6%, 8%, 6.7%, and 4%, respectively, in each of the following risk groups: primary immunodeficiency, asthma, chronic renal failure, congenital heart disease, chronic lung disease, leukemia, nephrotic syndrome, solid organ tumors, and type 1 diabetes mellitus. In the multivariate analysis, a history of otitis media within the last year, a history of pneumonia within the last year, and more than one sibling under 8 years of age were found to be independent risk factors for SPNP carriage.


Subject(s)
Carrier State/epidemiology , Carrier State/microbiology , Chronic Disease , Nasopharynx/microbiology , Pneumococcal Infections/epidemiology , Pneumococcal Infections/microbiology , Streptococcus pneumoniae/isolation & purification , Adolescent , Anti-Bacterial Agents/pharmacology , Carrier State/diagnosis , Child , Child, Preschool , Cross-Sectional Studies , Drug Resistance, Bacterial , Female , Humans , Infant , Male , Microbial Sensitivity Tests , Pneumococcal Infections/diagnosis , Prevalence , Risk Factors , Serogroup , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/immunology , Turkey/epidemiology , Young Adult
2.
Diagn Microbiol Infect Dis ; 92(2): 90-94, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29895404

ABSTRACT

The commercial Rapid Polymyxin NP test was evaluated to detect colistin-resistant Enterobacteriaceae. A total of 223 enterobacterial isolates corresponding to 136 resistant (including 38 MCR-like producers), 19 heteroresistant, and 78 colistin-susceptible isolates were tested. The test was performed according to the manufacturer's instruction, and the color of the wells was read after 2 and 3 hours of incubation. The results were compared with those of the homemade Rapid Polymyxin NP test, and manual broth microdilution according to EUCAST guidelines was used as the reference method to determine the performance of the test. Excellent performance of the commercial Rapid Polymyxin NP test was found with a very major error rate, a major error rate, a sensitivity, and a specificity of 1.9%, 5.1%, 98.1%, and 94.9%, respectively. The performance of the homemade Polymyxin NP test was similar, with a slightly better value for the very major error (1.2 %).


Subject(s)
Anti-Bacterial Agents/pharmacology , Colistin/pharmacology , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae/isolation & purification , Microbial Sensitivity Tests/methods , Polymyxins/pharmacology , Drug Resistance, Bacterial , Enterobacteriaceae/drug effects , Humans , Reagent Kits, Diagnostic , Sensitivity and Specificity , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...